Somatostatin receptors expressed on tumor cells form the rationale for somatostatin analog
treatment of patients with somatostatin receptor-positive neuroendocrine tumors …

BACKGROUND: Several animal and few human studies suggest the beneficial role of bone
marrow mesenchymal stem cells (MSCs) in liver cirrhosis. However, little is known about the …

In preclinical studies in rats we evaluated biodistribution and therapeutic effects of different
somatostatin analogs,[111In-DTPA] octreotide,[90Y-DOTA, Tyr3] octreotide and [177Lu …

Somatostatin and its analogues bind to somatostatin receptors (sst) 1 through 5 that are
overexpressed in neuroendocrine neoplasms such as gastroenteropancreatic (GEP) …

Background Auger electron emitters that can be targeted into DNA of tumour cells represent
an attractive systemic radiation therapy goal. In the situation of DNA-associated decay, the …

Background Peptide receptor scintigraphy with the radioactive somatostatin analogue,[111
In-DTPA 0] octreotide, is a sensitive and specific technique to show in vivo the presence and …

This review focuses on the present status of kidney protection during peptide receptor
radionuclide therapy (PRRT) using radiolabelled somatostatin analogues. This treatment …

There has been an exponential growth in the development of radiolabeled peptides for
diagnostic and therapeutic applications in the last decade. The automated means of …

Overexpression of the epidermal growth factor (EGF) receptor (EGFR) at levels up to 100
times higher than that observed on normal epithelial cells has been observed in 30% — …